avb-114
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2021 (NCT04847739)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04847739 | Phase 2 | Aug 31, 2021 | Robarts Clinical Trials, W.L.Gore & Associates |
| NCT06509828 | N/A | — | Robarts Clinical Trials, W.L.Gore & Associates |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Robarts Clinical Trials | For profit | 2 | 0 | 2 | 2021 |
| W.L.Gore & Associates | For profit | 2 | 2 | 2 | 2021 |
2 organizations
Page 1 / 1